SouthState’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
SouthState's JAZZ Position: Q3 2026 in Review
SouthState reduced its Jazz Pharmaceuticals (JAZZ) stake by 47% in Q3 2026, selling an estimated $2.22K and leaving 10 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #945.
SouthState first reported a position in JAZZ in Q1 2025 and has held it in 7 quarters since. The position peaked at $14.5K in Q2 2025. 542 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- SouthState held 10 shares of Jazz Pharmaceuticals worth $2.32K as of Q3 2026.
- SouthState sold 9 Jazz Pharmaceuticals shares in Q3 2026, an estimated $2.22K.
- Jazz Pharmaceuticals made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #945 holding.
- SouthState first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- SouthState's Jazz Pharmaceuticals position peaked at $14.5K in Q2 2025.
- 542 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.